healthcarenewswire

The protein expression market is expected to reach $3.0 billion by 2023, growing at a CAGR of 11.7% between 2017-2023. Key factors driving the growth of the market include increasing prevalence of chronic diseases, rise in the availability of funding for protein-based research, technological advancements, growing aging population and increasing growth in the life science sector.

Major players in the protein expression industry are developing products with technically advanced features that are designed to produce high protein yield, and maintain a balance of speed and scalability; thereby, enhancing its application in the drug development workflow. One of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by Thermo Fisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling up to 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products will drive the growth of the protein expression market during forecast period.

The single-cell analysis market size is projected to reach $5.3 billion by 2022, growing at a CAGR of 18.1% between 2016-2022. The market is driven by factors such as increasing healthcare expenditure, growing geriatric population, high prevalence of infectious diseases, technological advancements in single-cell analysis products, and growing focus on personalized medicines.

The European single-cell analysis market is expected to reach $1.6 billion by 2022. The market in Europe is witnessing growth mainly due to increasing prevalence of chronic diseases and infectious diseases, increase in the aging population, increase in the number of conferences & symposiums and increasing healthcare expenditure.  In terms of the type of product, the European single-cell analysis industry for consumables is expected to witness the fastest growth between 2016-2022. Also, in terms of the type of cell, the European single-cell analysis industry for human cell is expected to generate the highest revenue in 2022.

The advanced wound care market is growing due to increasing geriatric population and increasing awareness about these products combined with its increasing adoption. Increasing incidences cases of obesity and diabetes are also leading to increased demand for advanced wound care product. Among the different types of advanced wound care, the advanced wound dressing segment is expected to witness the fastest growth during the forecast period.

Advanced wound care product have better therapeutic efficacy as compared to the traditional wound care product, such as gauge, bandage, sponge and others. The utilization of advanced wound care product promote the wound healing process and reduces the recovery time. As a result, demand for advanced wound dressing, wound therapy device and active wound care product is expected to increase. These are used in both inpatient facilities and outpatient facilities to provide better treatment to patients suffering from burns, ulcers, surgical wounds and chronic wounds. Advanced wound dressing include foam dressing, hydrocolloid dressing, alginate dressing, film dressing, hydrogel dressing, collagen dressing and others. Wound therapy device include negative pressure wound therapy (NPWT) device, oxygen and hyperbaric oxygen equipment, electrical stimulation device, and others to promote wound healing. Active wound care product include artificial skin and skin substitutes and topical agents.

The CDSS market is driven by five major factors, including growing demand for advanced healthcare information systems, growing investments by HIT players, growing need for remote patient monitoring services, and increasing support from government organizations.

The massive unexplored CDSS across the globe has created abundant opportunities for the major players to exploit the potential of the CDSS market. Although, there has been significant development in the developed economies of European Union (EU) and the U.S., the clinical decision support system market is still at its nascent form, especially in the developing countries of Asia, Latin America, and Africa. A high growth in numbers of end user including hospitals, and pharmacy has been witnessed in the developing countries of these regions, which provides immense growth opportunities for the CDSS market.

The advanced visualization market size is expected to reach $3.8 billion by 2023, growing at a CAGR of 11.3% between 2017-2023. The market is witnessing a significant growth due to the technological advancements, increasing demand for efficient and early diagnosis of diseases, and rising prevalence of chronic diseases.

As per the findings of research, hardware and software held larger share in the advanced visualization market in 2016, primarily due to increasing installation of advanced visualization hardware and software in healthcare settings. The advanced visualization service market is expected to witness higher growth during the forecast period. The higher growth for services is attributed to the increasing demand for the implementation of advanced visualization solutions and training and education services. Among different type of advanced visualization solutions, enterprise-wide thin client-based solutions held larger share in the market in 2016, and it is also expected to witness higher growth during the forecast period. Improved data storage capacity, multi-user interface, centralized post-processing solutions, streamlined analysis, and enhanced data transfer capabilities of these solutions is significantly driving the growth of the global enterprise-wide thin client-based solutions market.

The global biosurgery market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure and growing sports related injuries. Moreover, growing prevalence of chronic diseases including cancer, cardiovascular disease, infectious diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases is supporting the growth of the market. Based on product type, the surgical sealants segment is expected to grow at the fastest rate during the forecast period. The increasing adoption of biosurgery products across the globe, owing to its ease of use, and its efficacy in blood loss management is driving the growth of this segment.

The rapid growth in emerging economies is expected to create opportunities for the manufacturers of biosurgery products. However, high cost of these products and lack of reimbursement are the key factors hampering the growth of the global market.